Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin.
Case Rep Oncol
; 13(3): 1402-1409, 2020.
Article
in En
| MEDLINE
| ID: mdl-33442363
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Case Rep Oncol
Year:
2020
Document type:
Article
Affiliation country:
Japón
Country of publication:
Suiza